| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2009 | CN100448479C Application of compound PSI in preparation of medicine for treating leucocythemia |
| 01/07/2009 | CN100448464C Synergistic medicinal composition for treating hepatitis |
| 01/07/2009 | CN100448463C Synergistic medicinal composition containing diammonium glycyrrhizicnate and Chinese medicine |
| 01/07/2009 | CN100448462C Synergistic medicinal composition containing diammonium glycyrrhizinate and Chinese medicine |
| 01/07/2009 | CN100448460C Herbal drug composition for cartilage protection |
| 01/07/2009 | CN100448459C Synergistic medicine composition for treating hepatitis |
| 01/07/2009 | CN100448457C Effective position of pilose asiabell root, preparation, medication use and preparation method |
| 01/07/2009 | CN100448454C Cancer treatment composition and method using natural plant essential oils |
| 01/07/2009 | CN100448453C A method of treating or preventing chronic wounds and a complete nutritional composition comprising glycine and/or leucine for use therein |
| 01/07/2009 | CN100448452C Remedies |
| 01/07/2009 | CN100448451C Nutritional compositions with contain slightly negatively charged, non-digestible polysaccharides and use thereof for reducing transport through tight junctions |
| 01/07/2009 | CN100448450C Pharyngolaryngitis-treating pharmaceutical compositions and its preparing method |
| 01/07/2009 | CN100448449C [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain |
| 01/07/2009 | CN100448448C Mesalazine controlled release oral pharmaceutical compositions |
| 01/07/2009 | CN100448447C Preparation of superfine prednisolone powder |
| 01/07/2009 | CN100448446C Buckthorn extract, its preparing method and use in pharmaceutical process |
| 01/07/2009 | CN100448445C Application of kuianchun family compound in anti-tumor drug preparing process |
| 01/07/2009 | CN100448444C Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 01/07/2009 | CN100448443C Nanometer antifungal econazole nitrate emulsion medicine and its prepn process |
| 01/07/2009 | CN100448442C Use of elastic protease inhibitor for preparing medicine for protecting cerebral hemorrhage |
| 01/07/2009 | CN100448441C Compsn. for treatment of burns |
| 01/07/2009 | CN100448440C Protective solution for preventing local ischemic damage |
| 01/07/2009 | CN100448439C Pharmaceutical compositions for headache, migraine, nausea and emesis |
| 01/07/2009 | CN100448438C Application of Schizandrin A on curing drug resistance for multiple drugs of treating tumors |
| 01/07/2009 | CN100448437C Method for the inhibition of atrophy or for treatment or prevention of atrophy-related symptoms in women |
| 01/07/2009 | CN100448433C Clarithromycin enteric medicinal composition |
| 01/07/2009 | CN100448432C Method for preparing nimodipine dispersible tablet with high dissolution |
| 01/07/2009 | CN100448431C Oral disintegrated Anfenmame tablet for treating children's cold and its prepn |
| 01/07/2009 | CN100448429C Water aqua containing clindamycin for treating acne |
| 01/07/2009 | CN100448374C Reducer of blood glucose level increase, reducer of body fat accumulation and food material |
| 01/07/2009 | CN100448358C Oil/fat composition |
| 01/06/2009 | USRE40618 Integrated cooling system |
| 01/06/2009 | US7473804 Polymorphs of atomoxetine hydrochloride |
| 01/06/2009 | US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 01/06/2009 | US7473787 Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 01/06/2009 | US7473784 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 01/06/2009 | US7473783 Bicyclic pyrazolo protein kinase modulators |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473771 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 01/06/2009 | US7473733 Cationic derivative of a water-soluble polysaccharide, cationic polyvinylalcohol, units derived from acrylic ester complexed with DNA; stable and soap-less latex; useful as a micro carrier for cell cultivation and immuno-adsorbent assay, gene transfer experiments, efficiency, transfection |
| 01/06/2009 | US7473711 Androgen modulators |
| 01/06/2009 | US7473710 Bronchodilating beta-agonist compositions and methods |
| 01/06/2009 | US7473709 11β-benzaldoxime derivatives of D-homooestra-4,9-dien-3-ones |
| 01/06/2009 | US7473708 Administering 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid or a derivative such as 20,20,20-trifluoromethyl-LTB4 to treat togavirus, orthomyxovirus, paramyxovirus, coronavirus, and filovirus infections |
| 01/06/2009 | US7473706 Compounds that stimulate glucose utilization and methods of use |
| 01/06/2009 | US7473705 Hexafluoroisopropanol substituted ether derivatives |
| 01/06/2009 | US7473704 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 01/06/2009 | US7473703 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia |
| 01/06/2009 | US7473702 Substituted gamma lactams as therapeutic agents |
| 01/06/2009 | US7473701 Substituted indazoles, compositions containing them, method of production and use |
| 01/06/2009 | US7473700 To treat fever, pain, and inflammation; Cyclooxygenase (COX-2) Inhibitors; Less side effects; 4-(3-mercapto-5-phenyl-1,2,4-triazole-1-yl)-benzenesulfonamide |
| 01/06/2009 | US7473699 antibiotic; Gram-positive pathogens (Staphylococci, Enterococci, and Streptococci ), MRSA and MRCNS; resistance to vancomycin and E. faecium to both aminoglycosides and beta--lactams; gram negative strains H.influenzae, M.catarrhalis and chlamydia; improved activity against mono-amine oxidase (MAO) |
| 01/06/2009 | US7473698 Secondary amino anilinic piperidines as MCH1 antagonists and uses thereof |
| 01/06/2009 | US7473697 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 01/06/2009 | US7473696 CCR-2 antagonist salt |
| 01/06/2009 | US7473695 4-imidazolin-2-one compounds |
| 01/06/2009 | US7473694 excellent inhibitory activity against MAPKAP-K2; inflammatory disorder, autoimmune diseases, destructive osteopathy, cancer and/or tumor growth; (4-ethoxyphenyl)(5-piperidin-3-yl-6,7-dihydro-5H-1,4,5,8a-tetraaza-s-indacen-8-yl)amine |
| 01/06/2009 | US7473693 pyrazine carboxamide compounds of sub-micron size; improve bioavailibility/absorption, exhibit no increase in size upon storage in the aqueous medium; N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide; using a precipitation process without the need for water-immiscible solvent; obesity |
| 01/06/2009 | US7473692 Sulfonamide derivatives as D3-receptor ligands |
| 01/06/2009 | US7473691 Pyrazole compounds useful as protein kinase inhibitors |
| 01/06/2009 | US7473690 Tetralin and indane derivatives and uses thereof |
| 01/06/2009 | US7473689 Short-acting benzodiazepines |
| 01/06/2009 | US7473688 Indolobenzazepine HCV NS5B inhibitors |
| 01/06/2009 | US7473686 Thrombopoietin mimetics |
| 01/06/2009 | US7473684 Bisphosphonate formulation |
| 01/06/2009 | US7473683 Nucleoside analog having a halogenated base consisting of a 1,3-dihalo-4-sugar-substitution-6-H, CH3 or imaging element-benzene; polynucleotide utilizing the analog as a substrate; inhibiting polymerization reactions, e.g. as antiviral agents, anti-proliferative agents; and as imaging agents |
| 01/06/2009 | US7473669 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides |
| 01/06/2009 | US7473525 Rna; anticancer agents |
| 01/06/2009 | US7473433 Pulmonary delivery of polyene antifungal agents |
| 01/06/2009 | US7473432 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 01/06/2009 | US7473431 Injectable methadone, methadone and naltrexone, or buprenorphine and naltrexone microparticle compositions and their use in reducing consumption of abused substances |
| 01/06/2009 | US7473429 Method for treatment of laminitis in animals |
| 01/06/2009 | US7473425 Remedies for ischemic disease |
| 01/06/2009 | US7473420 Processing adipose tissue to deliver a concentrated amount of stem cells in a closed system so that the stem cells are not exposed to external environment by use of a pre-assembled, linked set of closed, sterile containers and tubing allowing for transfer of tissue and fluid elements within a closed path |
| 01/06/2009 | US7473417 Polyphosphates, polyphosphonates and polyiminocarbonates fromed from iodinated or brominated bisphenols in which the rings are connected by groups including an (thio)amide, e.g., 3-(3-iodo-4-hydroxyphenyl)propanoic Acid-tyrosine Ethyl Ester; medical devices including stents |
| 01/06/2009 | US7473416 Medicaments for asthma treatment |
| 01/06/2009 | US7473268 Mating insertion instruments for spinal implants and methods of use |
| 01/06/2009 | CA2494321C 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 01/06/2009 | CA2486697C 3'-[(2z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 01/06/2009 | CA2478374C N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/06/2009 | CA2457642C Crystalline forms of ertapenem sodium |
| 01/06/2009 | CA2425812C Treatment of oppositional defiant disorder and conduct disorder with 5-amino-4,5,6,7-tetrahydro-4-oxyindolones |
| 01/06/2009 | CA2423572C Stabilization of solid thyroid drug formulations |
| 01/06/2009 | CA2423017C Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
| 01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
| 01/06/2009 | CA2417630C Novel compositions of minoxidil |
| 01/06/2009 | CA2414737C Pharmaceutical compositions containing tobramycin and xanthan gum |
| 01/06/2009 | CA2414095C Novel compounds |
| 01/06/2009 | CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/06/2009 | CA2404335C Vitamin d compounds used to stabilize kidney transplants |
| 01/06/2009 | CA2400818C Antibiotic and antifungal compositions |
| 01/06/2009 | CA2391297C 6-o-alkyl-2-nor-2-substituted ketolide derivatives |
| 01/06/2009 | CA2388957C Aromatic di-keto derivatives as glucose-6-phosphate translocase inhibitors |
| 01/06/2009 | CA2387058C Injection vehicle for polymer-based formulations |
| 01/06/2009 | CA2380231C Conditionally controlled, attenuated hiv vaccine |
| 01/06/2009 | CA2379086C 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 01/06/2009 | CA2371818C Salicylamide-lanthanide complexes for use as luminescent markers |
| 01/06/2009 | CA2369504C Pyrazole compositions useful as inhibitors of erk |
| 01/06/2009 | CA2349168C Hyaluronic acid gel, method of its production and medical material containing it |
| 01/06/2009 | CA2348084C Crystallisation using supercritical or subcritical fluids |